WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. | ![]() Actelion Pharmaceuticals Actelion Pharmaceuticals is a biopharmaceutical company focusing on the discovery, development, and commercialization of innovative treatments to serve high unmet medical needs. | ||
Founding Date | Founding Date 1993 | Founding Date 2010 | Founding Date 1997 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Hamburg, DE HQ Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE Munich, DE see more | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US | |
Employees | Employees 4,766 | Employees 12,575 | Employees 51712% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) €788.4m (FY, 2025) | Revenue (est.) ¥21.8b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €622.9m (FY, 2025) | Cost of goods ¥10b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €231.1m (FY, 2025) | Gross profit ¥12b (FY, 2025) | Gross profit N/A |
Net income | Net income (€103.5m) (FY, 2025) | Net income ¥5.7b (FY, 2025) | Net income N/A |
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
View company
Actelion Pharmaceuticals is a biopharmaceutical company focusing on the discovery, development, and commercialization of innovative treatments to serve high unmet medical needs.
View company